Nuevo proyecto en China

by Albian Group

Recientemente Albian Group ha conseguido marcar un nuevo hito en su trayectoria pues nos ha sido encomendado nuestro primer proyecto en China.

Read more

EMA Network strategy to 2025

by Asphalion

The European Medicines Agency Network Strategy to 2025 was detailed just last week during the 20th Regulatory Affairs and Pharmacovigilance conference.

Read more

Curso online: 'Novedades relacionadas con medicamentos en el entorno regulatorio europeo'. 4 y 5 de febrero, 2021

by Asphalion

Nuestros expertos Vicente Tur, Regulatory Affairs Director y Ramón Hernández Moratinos, Senior Regulatory Information Specialist, junto a Ana Viñas, Técnico de la AEMPS serán ponentes en el curso...

Read more

EMA 20th Regulatory Affairs and Pharmacovigilance Conference

by Asphalion

The 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.

Read more

BREXIT | What’s new for Pharma and Medical Devices

by Asphalion

Providing guidance about Regulatory Affairs and Trade changes in the Pharma and Medical Devices industries

Read more

GENESIS Biomed is reinforced by hiring a top-level advisory panel

by GENESIS Biomed

​ GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respe...

Read more

@MedtechEurope ( @FENIN_es ) publica el informe 'The European Medical Technology Industry in figures 2021'

by Tecno-med Ingenieros

En este informe se destaca el alto nivel de empleo del sector de tecnologías sanitarias

Read more

Interview Jaume Ruiz – Business Development Director and Senior Consultant at GENESIS Biomed

by GENESIS Biomed

Strong public-private collaboration in the research environment requires that health research institutions, through their transfer offices, offer an attractive portfolio of projects to the private sec...

Read more

Interview Oscar Alegre – Partner at DWF-RCD in the Innovation and Entrepreneurship Area, specialising in the Science and Technology Sector

by GENESIS Biomed

Nowadays there are international standards that are easily recognisable and accepted by all, which makes it much easier to close transactions regardless of the origin of the investor, especially in th...

Read more

La @AEMPSgob lanza la aplicación RPS de registro de responsables de la puesta en el mercado de productos sanitarios

by Tecno-med Ingenieros

Como anticipo al nuevo Real Decreto de productos sanitarios y el establecimiento del Registro de Comercialización la AEMPS pone en marcha esta nueva versión de RPS mejorada. Cualquier empresa establ...

Read more

GENESIS Biomed supports the creation of four spin-offs during 2021

by GENESIS Biomed

GENESIS Biomed has collaborated in the creation of many start-ups and spin-offs and at the beginning of the year 2022 we would like to mention all of these that, thanks to courageous researchers/entre...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Horizon pone en marcha una planta punter...

by Horizon Products

Horizon ha puesto en funcionamiento una nueva planta dedicada íntegra...

Photos Stream